Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol

Billinger, Michael; Räber, Lorenz; Seiler, Christian; Windecker, Stephan; Meier, Bernhard; Hess, Otto M (2004). Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol. European Heart Journal, 25(7), pp. 565-570. Oxford University Press 10.1016/j.ehj.2004.02.003

[img] Text
565.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (231kB) | Request a copy
[img]
Preview
Text
0.4000685.565.pdf - Other
Available under License Publisher holds Copyright.

Download (231kB) | Preview

BACKGROUND The use of ultrathin Doppler angioplasty guidewires has made it possible to measure collateral flow quantitatively. Pharmacologic interventions have been shown to influence collateral flow and, thus, to affect myocardial ischaemia. METHODS Twenty-five patients with coronary artery disease undergoing PTCA were included in the present analysis. Coronary flow velocities were measured in the ipsilateral (n = 25) and contralateral (n = 6; two Doppler wires) vessels during PTCA with and without i.v. adenosine (140 microg/kg.min) before and 3 min after 5 mg metoprolol i.v., respectively. The ipsilateral Doppler wire was positioned distal to the stenosis, whereas the distal end of the contralateral wire was in an angiographically normal vessel. The flow signals of the ipsilateral wire were used to calculate the collateral flow index (CFI). CFI was defined as the ratio of flow velocity during balloon inflation divided by resting flow. RESULTS Heart rate and mean aortic pressure decreased slightly (ns) after i.v. metoprolol. The collateral flow index was 0.25+/-0.12 (one fourth of the resting coronary flow) during the first PTCA and 0.27+/-0.14 (ns versus first PTCA) during the second PTCA, but decreased with metoprolol to 0.16+/-0.08 (p<0.0001 vs. baseline) during the third PTCA. CONCLUSIONS Coronary collateral flow increased slightly but not significantly during maximal vasodilatation with adenosine but decreased in 23 of 25 patients after i.v. metoprolol. Thus, there is a reduction in coronary collateral flow with metoprolol, probably due to an increase in coronary collateral resistance or a reduction in oxygen demand.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Billinger, Michael; Räber, Lorenz; Seiler, Christian; Windecker, Stephan; Meier, Bernhard and Hess, Otto

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0195-668X

Publisher:

Oxford University Press

Language:

English

Submitter:

Lorenz Räber

Date Deposited:

06 Mar 2014 22:24

Last Modified:

27 Apr 2018 11:21

Publisher DOI:

10.1016/j.ehj.2004.02.003

PubMed ID:

15120053

BORIS DOI:

10.7892/boris.43475

URI:

https://boris.unibe.ch/id/eprint/43475

Actions (login required)

Edit item Edit item
Provide Feedback